Abstract
The focus of this chapter is on toxoplasmosis, Rocky Mountain spotted fever (RMSF), trichinosis, giardiasis, psittacosis, Ebola virus, Lyme disease, and hantavirus. Most of these illnesses are zoonotic in nature. Physicians should be familiar with their diagnosis, evaluation, and treatment.
Similar content being viewed by others
References
Schlüter D, Däubener W, Schares G, Groß U, Pleyer U, Lüder C. Animals are key to human toxoplasmosis. Int J Med Microbiol. 2014;304:917. pii: S 1438-4221(14)00118-0.
Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animal to humans. Int J Parasitol. 2000;30:1217.
Heller HM. Toxoplasmosis in immunocompetent hosts. In: Up to Date Weller PF, (ED). Up-to-date, Waltham, MA Topic 5699 ver 9.0; 2015.
Lefevre-Pettazzoni M, Le Cam S, Wallon M, Peyron F. Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women. Eur J Clin Microbiol Infect Dis. 2006;25(11):687.
Dupouy-Camet J, de Souza SL, Maslo C, Paugam A, Saimot AG, Benarous R, Tourte-Schaefer C, Derouin F. Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction. J Clin Microbiol. 1993;31(7):1866.
Kaplan S. Current therapies in pediatric infectious disease. 3rd ed. St Louis: Mosby-Year Book; 1993. p. 344–345.
Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis. 1995;20(5):1118–21.
Holman RC, McQuiston JH, Haberling DL, Cheek JE. Increasing incidence of Rocky Mountain spotted fever among the American Indian population in the United States. Am J Trop Med Hyg. 2009;80(4):601–5.
Dalton MJ, Clarke MJ, Holman RC, Krebs JW, Fishbein DB, Olson JG, et al. National surveillance for Rocky Mountain spotted fever, 1981–1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg. 1995;52(5):405–13.
Alvarez-Hernandez G, Murillo-Benitez C, Del Carmen Candia-Plata M, Moro M. Clinical profile and predictors of fatal rocky Mountain spotted fever in children from Sonora, Mexico. Pediatr Infect Dis J. 2014; 34(2):125–30.
Minniear TD, Buckingham SC. Managing Rocky Mountain spotted fever. Expert Rev Anti Infect Ther. 2009;7(9):1131–7.
Sexton DJ, Corey GR. Rocky Mountain “spotless” and “almost spotless” fever: a wolf in sheep’s clothing. Clin Infect Dis. 1992;15(3):439–48.
Helmick CG, Bernard KW, D’Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984;150(4):480–8.
Doyle A, Bhalla KS, Jones 3rd JM, Ennis DM. Myocardial involvement in Rocky Mountain spotted fever: a case report and review. Am J Med Sci. 2006;332(4):208–10.
McQuiston JH, Wiedeman C, Singleton J, Carpenter LR, McElroy K, Mosites E, et al. Inadequacy of IgM antibody tests for diagnosis of Rocky Mountain spotted fever. Am J Trop Med Hyg. 2014;91(4):767–70.
Kaplan JE, Schonberger LB. The sensitivity of various serologic tests in the diagnosis of Rocky Mountain spotted fever. Am J Trop Med Hyg. 1986;35(4):840–4.
Treadwell TA, Holman RC, Clarke MJ, Krebs JW, Paddock CD, Childs JE. Rocky Mountain spotted fever in the United States, 1993–1996. Am J Trop Med Hyg. 2000;63(1–2):21–6.
Devleeschauwer B, Praet N, Speybroeck N, Torgerson PR, Haagsma JA, De Smet K, et al. The low global burden of trichinellosis: evidence and implications. Int J Parasitol. 2014;45(2–3):95–9. doi:10.1016/j.ijpara.2014.05.006.
Pozio E, Zarlenga DS. New pieces of the Trichinella puzzle. Int J Parasitol. 2013;43(12–13):983–97.
Kennedy ED, Hall RL, Montgomery SP, Pyburn DG, Jones JL, Centers for Disease Control and Prevention (CDC). Trichinellosis surveillance – United States, 2002–2007. MMWR Surveill Summ. 2009;58(9):1–7.
Yoder JS, Gargano JW, Wallace RM, Beach MJ. Giardiasis surveillance –United States, 2009–2010. Morb Mortal Wkly Rep CDC Survei Sum. 2012;61(SS-05):12–23.
Adam RD. Biology of Giardia lamblia. Clin Microbiol Rev. 2001;14(3):447–75.
Solaymani-Mohannadis S, Singer SM. Giardia duodenalis the double-edge sword of immune response in giardiasis. Exp Parasitol. 2010;126(3):292–7.
Muhsen K, Levine MM. A systematic review and meta-analysis of the association between Giardia Lamblia and endemic pediatric diarrhea in developing countries. Clin Infect Dis. 2012;55 Suppl 4:S271–93.
McHandy IH, Wu M, Shimizu-Cohen R. Detection of intestinal protozoa in the clinical laboratory. Clin Microbiol. 2014;52(3):712–20. doi:10.1128/JCM.02877-13.
Garden TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev. 2001;14(1):114–28.
Funk DJ, Kumar A. Ebola virus disease: an update for anesthesiologists and intensivists. Can J Anaesth. 2014;62(1):80–91. doi:10.1007/s12630-014-0257-z.
Nyenswah T, Fahnbulleh M, Massaquoi M, et al. Ebola epidemic—Liberia, March–October 2014. MMWR Morb Mortal Wkly Rep. 2014;63:1082–6.
WHO Ebola Response Team. Ebola virus disease in West Africa – the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371(16):1481–95.
Fausther-Bovendo H, Mulangu S, Sullivan NJ. Ebolavirus vaccines for humans and apes. Curr Opin Virol. 2012;2(3):324–9.
Borchers AT, Keen CL, Huntley AC, Gershwin ME. Lyme disease: a rigorous review of diagnostic criteria and treatment. J Autoimmun. 2015;57:82–115. doi:10.1016/j.jaut.2014.09.004.
Murray TS, Shapiro ED. Lyme disease. Clin Lab Med. 2010;30(1):311–28.
Wright WF, Riedel DJ, Talwani R, Gilliam BL. Diagnosis and management of Lyme disease. Amm Fam Physician. 2012;85(11):1086–93.
Biesiada G, Czepiel J, Lesniak MR, Garlicki A, Mach T. Lyme disease: review. Arch Med Sci. 2012;8(6):978–82.
Dunaj J, Moniuszko A, Zajkowska J, Pancewicz S. The role of PCR in diagnostics of Lyme borreliosis. Przegl Epidemiol. 2013;67:35–9.
Vaheri A, Strandin T, Hepojoki J. Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol 2013:539–50. Nature.com. Web. http://www.nature.com/nrmicro/journal/v11/n8/full/nrmicro3066.html
Outbreak of hantavirus infection in Yosemite National Park. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. 2012. Web. 15 Jan 2015. http://www.cdc.gov/hantavirus/outbreaks/yosemite-national-park-2012.html
Kruger D, Figueiredo L, Song J-W, Klempa B. Hantaviruses-globally emerging pathogens. J Clin Virol. 2014;88:811. Elsevier.
Holmes EC, Zhang YZ. The evolution and emergence of hantaviruses. Curr Opin Virol. 2014;10:27–33. doi:10.1016/j.coviro.2014.12.007. Elsevier.
Kaya S. Prognostic factors in hantavirus infections. Mikrobiyol Bül. 2014:n. page. National Center for Biotechnology Information. U.S. National Library of Medicine. Web. 15 Jan 2015. http://www.ncbi.nlm.nih.gov/pubmed/24506730
Schmaljon C, Hjelle B. Hantaviruses-globally emerging pathogens. Emerg Infect Dis. 1997;3(2):95–104. National Center for Infectious Diseases, Centers for Disease Control and Prevention
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this entry
Cite this entry
Arango, C.A., Shah, N., Nalamalapu, S.R. (2015). Selected Infectious Diseases. In: Paulman, P., Taylor, R. (eds) Family Medicine. Springer, Cham. https://doi.org/10.1007/978-1-4939-0779-3_46-1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0779-3_46-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-1-4939-0779-3
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Selected Infectious Diseases- Published:
- 06 July 2020
DOI: https://doi.org/10.1007/978-1-4939-0779-3_46-2
-
Original
Selected Infectious Diseases- Published:
- 05 October 2015
DOI: https://doi.org/10.1007/978-1-4939-0779-3_46-1